RIA
IDNA icon

Realta Investment Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Realta Investment Advisors’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-407
Closed -$9.41K – 532
2024
Q2 		$9.41K Hold
407
– – ﹤0.01% 678
2024
Q1 		$9.8K Buy
+407
New +$9.54K ﹤0.01% 699
2020
Q1 		– Sell
-407
Closed -$12K – 797
2019
Q4 		$12K Buy
+407
New +$11.1K ﹤0.01% 1082

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
CCA
Cora Capital Advisors Marlton, New Jersey $302M AUM 16.46% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Realta Investment Advisors's IDNA Position: Q3 2024 in Review

Realta Investment Advisors sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2024, closing a stake of 407 shares — an estimated $9.41K sold.

Realta Investment Advisors first reported a position in IDNA in Q4 2019 and held it in 3 quarters. The position peaked at $12K in Q4 2019. 53 funds tracked by Wall St. Rank hold IDNA as of Q3 2024.

  • Realta Investment Advisors reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q3 2024 after selling out during the quarter.
  • Realta Investment Advisors sold 407 iShares Genomics Immunology and Healthcare ETF shares in Q3 2024, an estimated $9.41K.
  • Realta Investment Advisors first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2019 and held it in 3 quarters.
  • Realta Investment Advisors's iShares Genomics Immunology and Healthcare ETF position peaked at $12K in Q4 2019.
  • 53 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2024.

Based on Realta Investment Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.